Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection

C. Martinelli, A. Farese, A. Del Mistro, S. Giorgini, I. Ruffino

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Anogenital condylomata acuminata are the most frequent clinical manifestation of genital human papillomavirus (HPV) infection. Association between human immunodeficiency virus (HIV) and HPV infections is frequent (range: 26-60% in males). Topical cidofovir (a nucleotide analogue antiviral drug active against a broad range of DNA viruses) is a potential treatment for anogenital warts in immunocompromised patients. We treated three HIV-infected patients with HPV perianal condylomas with topical 1% cidofovir in flexible collodion once a day for 2 weeks. The treatment resulted in complete clearance of the HPV lesions. The patients experienced mild transient erythema without any other side-effects. None of the patients relapsed during the 10-14-month follow-up period.

Original languageEnglish
Pages (from-to)568-569
Number of pages2
JournalJournal of the European Academy of Dermatology and Venereology
Volume15
Issue number6
DOIs
Publication statusPublished - 2001

Fingerprint

Condylomata Acuminata
Virus Diseases
HIV
Papillomavirus Infections
Warts
DNA Viruses
Collodion
Immunocompromised Host
Erythema
Antiviral Agents
Nucleotides
cidofovir
Therapeutics

Keywords

  • Cidofovir
  • Condylomas
  • HIV

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection. / Martinelli, C.; Farese, A.; Del Mistro, A.; Giorgini, S.; Ruffino, I.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 15, No. 6, 2001, p. 568-569.

Research output: Contribution to journalArticle

@article{9ad3e17caf2b4d569a6a08986b809007,
title = "Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection",
abstract = "Anogenital condylomata acuminata are the most frequent clinical manifestation of genital human papillomavirus (HPV) infection. Association between human immunodeficiency virus (HIV) and HPV infections is frequent (range: 26-60{\%} in males). Topical cidofovir (a nucleotide analogue antiviral drug active against a broad range of DNA viruses) is a potential treatment for anogenital warts in immunocompromised patients. We treated three HIV-infected patients with HPV perianal condylomas with topical 1{\%} cidofovir in flexible collodion once a day for 2 weeks. The treatment resulted in complete clearance of the HPV lesions. The patients experienced mild transient erythema without any other side-effects. None of the patients relapsed during the 10-14-month follow-up period.",
keywords = "Cidofovir, Condylomas, HIV",
author = "C. Martinelli and A. Farese and {Del Mistro}, A. and S. Giorgini and I. Ruffino",
year = "2001",
doi = "10.1046/j.1468-3083.2001.00288.x",
language = "English",
volume = "15",
pages = "568--569",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "6",

}

TY - JOUR

T1 - Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection

AU - Martinelli, C.

AU - Farese, A.

AU - Del Mistro, A.

AU - Giorgini, S.

AU - Ruffino, I.

PY - 2001

Y1 - 2001

N2 - Anogenital condylomata acuminata are the most frequent clinical manifestation of genital human papillomavirus (HPV) infection. Association between human immunodeficiency virus (HIV) and HPV infections is frequent (range: 26-60% in males). Topical cidofovir (a nucleotide analogue antiviral drug active against a broad range of DNA viruses) is a potential treatment for anogenital warts in immunocompromised patients. We treated three HIV-infected patients with HPV perianal condylomas with topical 1% cidofovir in flexible collodion once a day for 2 weeks. The treatment resulted in complete clearance of the HPV lesions. The patients experienced mild transient erythema without any other side-effects. None of the patients relapsed during the 10-14-month follow-up period.

AB - Anogenital condylomata acuminata are the most frequent clinical manifestation of genital human papillomavirus (HPV) infection. Association between human immunodeficiency virus (HIV) and HPV infections is frequent (range: 26-60% in males). Topical cidofovir (a nucleotide analogue antiviral drug active against a broad range of DNA viruses) is a potential treatment for anogenital warts in immunocompromised patients. We treated three HIV-infected patients with HPV perianal condylomas with topical 1% cidofovir in flexible collodion once a day for 2 weeks. The treatment resulted in complete clearance of the HPV lesions. The patients experienced mild transient erythema without any other side-effects. None of the patients relapsed during the 10-14-month follow-up period.

KW - Cidofovir

KW - Condylomas

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=0035673369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035673369&partnerID=8YFLogxK

U2 - 10.1046/j.1468-3083.2001.00288.x

DO - 10.1046/j.1468-3083.2001.00288.x

M3 - Article

C2 - 11843219

AN - SCOPUS:0035673369

VL - 15

SP - 568

EP - 569

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 6

ER -